Board Appointment : Non-Execu

RNS Number : 2672E
Dechra Pharmaceuticals PLC
17 December 2009
 




Issued by Citigate Dewe Rogerson Ltd, Birmingham

Date: Thursday, 17 December 2009


Dechra® Pharmaceuticals PLC

("Dechra" or the "Company")

Board Appointment

Non-Executive Director


Dechra is pleased to announce the appointment of Bryan Morton as a Non-Executive Director with effect from 7 January 2010.


Bryan has a 30 year career in the pharmaceutical industry, largely with Merck & Co. Inc. and Bristol Myers Squibb where he has held positions of responsibility within marketing, sales, business development and general management.


In 2003 Bryan founded Zeneus Pharma, an oncology and critical care bio-pharmaceutical company which was sold in 2005.  Bryan is currently President and Chief Executive Officer of EUSA Pharma, a specialist pharmaceutical company focussing on oncology, pain control and critical care, which he founded in 2006.


Dechra's Chairman, Michael Redmond, said "The Board is delighted that Bryan has accepted the position of Non-Executive Director and we look forward to working with him to further strengthen Dechra's reputation as a leading international veterinary pharmaceutical business."


There are no other matters which require to be disclosed pursuant to paragraph 9.6.13R of the Listing Rules.


Enquiries:


Ian Page, Chief Executive 

Fiona Tooley, Director

Dechra Pharmaceuticals PLC

Citigate Dewe Rogerson

Tel: +44 (0)1782 771100

Tel: +44 (0)121 362 4035

Mobile: 07775 642222 (IP)

Mobile: 07785 703523 (FMT)

www.dechra.com


corporate.enquiries@dechra.com




Trademarks appear throughout this release in italics. Dechra and the Dechra 'D' logo are registered Trademarks of Dechra Pharmaceuticals PLC.


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOAGUGAGPUPBPUQ
UK 100

Latest directors dealings